[{"Assets_0_Q3_USD":194981000.0,"CommonStockSharesOutstanding_0_Q3_shares":39835500.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-32974000.0,"NetIncomeLoss_1_Q3_USD":-16089000.0,"NetIncomeLoss_3_Q3_USD":-47199000.0,"StockholdersEquity_0_Q3_USD":143620000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"Ticker":"RCKT","CIK":"1281895","name":"ROCKET PHARMACEUTICALS, INC.","OfficialName":"Rocket Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"879860326.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]